Depression, Unipolar
50
10
11
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.0%
2 terminated out of 50 trials
92.3%
+5.8% vs benchmark
6%
3 trials in Phase 3/4
42%
10 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (50)
Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled Trial
IM Ketamine vs Midazolam for Suicidal ER Patients
Natural History of Depression, Bipolar Disorder and Suicide Risk
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness
Repeated Neurocognitive Measurements in Depressed Patients
Pramipexole to Target "Anhedonic Depression"
SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project
Development and Evaluation of a Digital Aftercare Program for Adolescents (12-17 Years) With Depressive Symptoms After Hospital Discharge (Mind-WIN Pilot Study) (Mind-WIN Pilot)
Psychotherapy Feasibility Pilot of the Carolina Recovery From Depression Protocol
FMRI-neurofeedback in Depression
Intermittent Theta-burst Stimulation for Major Depression: an Intensity-response Study
Pilot Study: Investigating Mood Changes After Slow-wave Enhancement
BioClock: Bright Light Therapy for Depressive Disorders
Novel Neural Circuit Biomarkers of Major Depression Response to CCBT
Repeated Neurocognitive Measurements in Depressed Patients
Ketamine + Mindfulness for Depression
The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression
Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression
LIVES: Personalized Lifestyle Intervention for Patients With Depression